Ruggaard & Associates’s Ambev ABEV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEV
SCP
NAMI
BIP
ETC
Ruggaard & Associates's ABEV Position: Q2 2026 in Review
Ruggaard & Associates held its Ambev (ABEV) position steady in Q2 2026 at 10,000 shares worth $31.4K. The position accounts for 0.01% of the portfolio, ranked #127.
Ruggaard & Associates first reported a position in ABEV in Q1 2023 and has held it in 14 quarters since. The position peaked at $31.8K in Q2 2023. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.
- Ruggaard & Associates held 10,000 shares of Ambev worth $31.4K as of Q2 2026.
- Ruggaard & Associates left its Ambev share count unchanged in Q2 2026.
- Ambev made up 0.01% of Ruggaard & Associates's portfolio in Q2 2026, its #127 holding.
- Ruggaard & Associates first reported a position in Ambev in Q1 2023 and has held it in 14 quarters since.
- Ruggaard & Associates's Ambev position peaked at $31.8K in Q2 2023.
- 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.
Based on Ruggaard & Associates's 13F filing for Q2 2026, filed 17 Aug 2026.